Vital Farms (NASDAQ:VITL – Get Free Report) had its price objective dropped by equities researchers at Needham & Company LLC from $14.00 to $13.00 in a research note issued to investors on Wednesday, Benzinga reports. The firm currently has a “buy” rating on the stock. Needham & Company LLC‘s price target suggests a potential upside of 29.74% from the company’s previous close.
VITL has been the subject of several other reports. Stifel Nicolaus dropped their target price on Vital Farms from $11.00 to $9.00 and set a “hold” rating for the company in a research report on Thursday, October 15th. Benchmark raised shares of Vital Farms from a “hold” rating to a “buy” rating in a research report on Thursday, August 6th. Weiss Ratings lowered shares of Vital Farms from a “sell (d+)” rating to a “sell (d)” rating in a research note on Tuesday, September 29th. BMO Capital Markets reissued an “outperform” rating on shares of Vital Farms in a research note on Wednesday. Finally, TD Cowen dropped their price objective on shares of Vital Farms from $11.00 to $8.00 and set a “hold” rating for the company in a report on Tuesday, October 13th. Six research analysts have rated the stock with a Buy rating, seven have given a Hold rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat.com, the company has an average rating of “Hold” and an average price target of $16.45.
Read Our Latest Analysis on VITL
Vital Farms Trading Up 9.2%
VITL opened at $10.02 on Wednesday. Vital Farms has a 52 week low of $7.95 and a 52 week high of $38.64. The company has a quick ratio of 0.60, a current ratio of 1.10 and a debt-to-equity ratio of 0.11. The business has a fifty day simple moving average of $9.73 and a 200-day simple moving average of $13.96. The firm has a market cap of $430.16 million, a P/E ratio of -250.50 and a beta of 1.16.
Vital Farms (NASDAQ:VITL – Get Free Report) last posted its quarterly earnings data on Tuesday, November 3rd. The company reported ($0.15) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.11) by ($0.04). Vital Farms had a net margin of 0.02% and a return on equity of 3.46%. The firm had revenue of $182.16 million during the quarter, compared to analysts’ expectations of $181.78 million. During the same quarter in the prior year, the firm posted $0.36 EPS. Vital Farms’s quarterly revenue was down 8.4% compared to the same quarter last year. On average, equities analysts expect that Vital Farms will post -0.53 earnings per share for the current year.
Institutional Trading of Vital Farms
Hedge funds have recently modified their holdings of the stock. BlackRock Inc. purchased a new position in Vital Farms in the second quarter valued at $60,153,000. Van Berkom & Associates Inc. grew its stake in Vital Farms by 1,998.7% during the 1st quarter. Van Berkom & Associates Inc. now owns 2,261,533 shares of the company’s stock worth $31,933,000 after purchasing an additional 2,153,775 shares in the last quarter. Principal Financial Group Inc. increased its holdings in Vital Farms by 41.6% during the 1st quarter. Principal Financial Group Inc. now owns 2,153,008 shares of the company’s stock worth $30,400,000 after purchasing an additional 632,537 shares during the period. Dimensional Fund Advisors LP increased its holdings in Vital Farms by 46.8% during the 1st quarter. Dimensional Fund Advisors LP now owns 1,405,032 shares of the company’s stock worth $19,836,000 after purchasing an additional 447,728 shares during the period. Finally, Cibc World Market Inc. purchased a new stake in Vital Farms during the 2nd quarter worth about $12,975,000. 98.59% of the stock is currently owned by institutional investors and hedge funds.
Key Stories Impacting Vital Farms
Here are the key news stories impacting Vital Farms this week:
- Positive Sentiment: Craig Hallum upgraded VITL from “hold” to “buy” and set a $12 price target, citing potential upside from the share price reported at the time. Craig Hallum rating
- Negative Sentiment: Q3 results showed a loss of $0.15 per share, worse than the roughly $0.11–$0.13 loss expected, versus earnings of $0.36 a year earlier. Revenue was about $182.2 million—near analyst estimates—but down 8.4% year over year. Q3 results
- Negative Sentiment: Vital Farms expects approximately $730 million in 2026 net sales but an adjusted EBITDA loss of about $15 million, and withdrew its 2030 targets. The weaker profitability outlook and reduced long-term visibility weigh on the investment case. 2026 outlook
- Negative Sentiment: A report also flagged litigation and accounting/financial-operations risks amid volatile egg markets, adding uncertainty for investors. Risk report
About Vital Farms
Vital Farms, Inc is a food company that produces and markets pasture-raised eggs and other ethically sourced food products. Its offerings include pasture-raised eggs, butter, hard-boiled eggs and ghee, sold under the Vital Farms brand.
Founded in 2007, the company works with a network of family farms and focuses on animal welfare, outdoor access and supply-chain transparency. Vital Farms products are distributed primarily through grocery retailers and other food channels across the United States.
Vital Farms is headquartered in Austin, Texas.
Further Reading
- Five stocks we like better than Vital Farms
- Shopify’s Small Q3 Miss Triggered a Big Sell-Off: What’s Next?
- Can Oil’s Big Rally Deliver Reliable Income? 3 Energy Plays to Watch
- Marriott’s Earnings Beat Shows Why It’s More Than a Bet on Travel Demand
- Franklin Templeton’s New ETFs Turn Stock Dividends Into Bitcoin—What’s the Catch?
Receive News & Ratings for Vital Farms Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vital Farms and related companies with MarketBeat.com's FREE daily email newsletter.
